1832 Asset Management’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
SL
1832 Asset Management's ONC Position: Q4 2025 in Review
1832 Asset Management sold out of BeOne Medicines (ONC) in Q4 2025, closing a stake of 80,000 shares — an estimated $27.3M sold.
1832 Asset Management first reported a position in ONC in Q4 2020 and held it in 7 quarters. The position peaked at $27.3M in Q3 2025. 288 funds tracked by Wall St. Rank hold ONC as of Q4 2025.
- 1832 Asset Management reported no remaining BeOne Medicines position as of Q4 2025 after selling out during the quarter.
- 1832 Asset Management sold 80,000 BeOne Medicines shares in Q4 2025, an estimated $27.3M.
- 1832 Asset Management first reported a position in BeOne Medicines in Q4 2020 and held it in 7 quarters.
- 1832 Asset Management's BeOne Medicines position peaked at $27.3M in Q3 2025.
- 288 funds tracked by Wall St. Rank held BeOne Medicines as of Q4 2025.
Based on 1832 Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.